發送短信 : Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials

 __   _      ___      _____     ______    ____    
| || | ||   / _ \\   / ____||  /_   _//  |  _ \\  
| '--' ||  | / \ || / //---`'   -| ||-   | |_| || 
| .--. ||  | \_/ || \ \\___     _| ||_   | .  //  
|_|| |_||   \___//   \_____||  /_____//  |_|\_\\  
`-`  `-`    `---`     `----`   `-----`   `-` --`